Ethical, social, and legal dimensions of screening for human genetic disease / editor, Daniel Bergsma ; Genetics Research Group of the Institute of Society, Ethics and the Life Sciences.

Date:
1974
Catalogue details

Licence: Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)

Credit: Ethical, social, and legal dimensions of screening for human genetic disease / editor, Daniel Bergsma ; Genetics Research Group of the Institute of Society, Ethics and the Life Sciences. Source: Wellcome Collection.

    281/288 (page 269)
    SUBJECT INDEX Sanctity of life, 232,249 protection of, 232 integrity of the person, 232 nonmaleficience, 233 Schizophrenia, 104 Screenee educational programs for, content, 141 individual rights, 62,67,165,169 protection of, 75 responsibility of, 230,235 risks, need for documentation of, 140 Screener accountabihty, 229 concerns of, 169 lay duties of, 61 licensure of, 64 liability of, 59,65 obligations of, 28 orientation of, 169 responsibilities of, 142 screener-screenee relationship, 59 Screening {see compulsory, chromo¬ somal, genetic, mass, newborn and multiphasic) attitude toward, 28 automated technics, 11 benefits, 26 consent in, 13 cost-effectiveness of, 26 criteria for, 27,28 efficiency of, 30 ethical questions, 13 evaluation of, 27 funds for, 15 goals of, 28 history of, 26 laws communicability and, 38 constitutionahty of, 38 Massachusetts program, 8,9,11 multiphasic programs, 4 multiple testing, 8,12 philosophic considerations, 2 political considerations, 2,3 prescriptive, 19 program establishment, 10,13 follow-up, 14 regional testing centers, 13 testing materials, cost, 13 purposes of, 2,25,50,69 quarantine as part of, 3 sociologic/psychologic factors and, 27, 45 technologic imperative, 48 tests, reliability of, 35 valid classifications for, 77 validity of, 12 value assumptions, 2 Sickle cell anemia, 32, 34, 35, 44, 191, 192,193,209,220,244 deleterious effects of screening, 212 frequency, 205 genetic counseling for, 195 marital status and, 210 severity of, 194 stigmatization and, 211 therapy of, 193 Sickle cell heterozygote, 37 in Greece, 45 voluntary screening for, 38 Sickle cell screening, 32,77 laws mandating, 38,40,44,50 organization of, 37 premarital, 38 problems associated with, 37 Sickle cell trait, 35,207 genetic counseling for, 195 insurance premiums and, 193 mihtary recruiting and, 36 pathogenesis of, 195 penalties for carrying, 211 possible hazards of, 36 premarital testing for, 38 psychologic reaction to, 195 response of black community to screening, 243,244 Sex-chiomatin technic, 128 Sex predetermination, 22-6 Social worth, 256,257 Spina bifida alpha-fetoprotein, 116 amino acids, 116 endoamnioscope, 115 5-hydroxyindole, 116 phenotypic variability in, 113 quality of life, 114 selection for surgery, 114